The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted 9-0 that tofersen’s effect on neurofilament light chain (NfL) could be a reasonable predictor of clinical benefit.
FDA Adcomm Backs Accelerated Approval of Biogen’s Tofersen in SOD1-ALS Read More »
La edición de bases es una forma ultraprecisa de edición del genoma que permite a los científicos corregir mutaciones de una sola letra en el ADN. El ADN se compone de cuatro bases químicas denominadas abreviadamente A, T, C y G. Esas bases se emparejan para formar los &q …
Un logro de una nueva técnica para modificar el genoma humano Read More »
Por vez primera, unos científicos han demostrado la capacidad de manipular e identificar pequeñas cantidades de fotones interactuantes con alta correlación. La investigación en la que se ha comprobado esto la ha llevado a cabo el equipo de Sahand Mahmoodian, de l …
Un nuevo estudio ha permitido elaborar el primer mapa detallado de la distribución del agua en la Luna. El estudio se ha hecho a partir de observaciones que realizó el observatorio aéreo SOFIA (por las siglas de Stratospheric Observatory For Infrared Astronomy), de la N …
Noticias de la actualidad científica y tecnológica del 20 de marzo de 2023. …
Enveric Biosciences, Inc. today announced that it has entered into an agreement with Avance Clinical for its planned Phase 1 clinical trial of EB-373, the company’s lead candidate targeting the treatment of anxiety disorders.
Rodney Varner , CEO of Genprex, Inc. today commended The U.S. Food and Drug Administration’s (FDA) initiative that aims to expedite the development of gene therapies for patients with rare diseases.
Genprex CEO Commends FDA’s Initiative to Accelerate Approval Process for Gene Therapies Read More »
Xenetic Biosciences, Inc. today reported its financial results for the full year 2022 and provided a business update.
Vividion Therapeutics, Inc. today announced that Matt Patricelli, Ph.D. has been promoted to Chief Scientific Officer.
Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read More »
Pragma Bio developed a first-of-its-kind-map of chemicals designed by nature, housed in humans, and linked to immune-related health outcomes
